Diabetic chronic HCV patients and their response to interferon therapy

Changes in immunomodulators in relation to interferon therapy in hepatitis c virus infection

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Studying the possible role of HCV genotypes and quasispecies in relation to peginterferon treatment

Impact of serum levels of AFP onresponse to treatment ingenotype 4 chronic HCV patients

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

The clinical significance of IL-10 and IL-12B gene Polymorphisms as predictor of response to HCV patients treated by peginterferon plus ribavirin

Study of prediction of response to pegylated interferon plus ribavirin in hepatitis C patients by IL28B gene variation and its relation to other different predictors

Aetiology of anemia in chronic HCV patients receiving pegylated interferon plus ribavirin

Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C